Skip to content

Transcranial Doppler During Liver Transplantation

Transcranial Doppler and Neurological Complications After Liver Transplantation

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05144451
Enrollment
100
Registered
2021-12-03
Start date
2021-11-28
Completion date
2024-04-28
Last updated
2022-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complication, Postoperative, Liver Transplantation, Neurologic Deficits, Ultrasonography, Doppler, Transcranial

Brief summary

This is a prospective study that would investigate the transcranial doppler (TCD) changes during the living donor liver transplantation and the association between the TCD changes and the post-transplant neurological complications.

Detailed description

Objectives: Participants & Setting: Intervention & Measurements: Sample size:

Interventions

DIAGNOSTIC_TESTTranscranial Doppler

Transcranial Doppler-derived parameters; pulsatility index (PI), resistance index (RI), mean flow velocity (Vmean) will be recorded before induction of anesthesia (T1). After induction, TCD parameters, Hemodynamic variables including heart rate (HR), invasive mean arterial blood pressure (MAP), and central venous pressure (CVP) together with Arterial blood gases (ABG analysis with values of PH, PCO2, PO2, blood oxygen saturation SO2 and bicarbonate HCO3), end-tidal carbon dioxide (ETCO2) and body temperature will be recorded too. Just before skin incision (T2), at the end of anhepatic phase 5 minutes before reperfusion (T3), 5 minutes after reperfusion (T4) and at the end of surgery (T5). Postoperatively at ICU, TCD parameters, Hemodynamic variables, and ABG will be obtained 24 hours postoperative (T6) and at discharge from ICU (T7).

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Intervention model description

A single-arm trial involving 100 patients undergoing living donor liver transplantation; all will be examined using transcranial doppler to find out its predictive value on post-transplant neurological deficits.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* all patients scheduled for living donor liver transplantation for whatever the indication at Gastrointestinal surgery center (GISC)

Exclusion criteria

* Patients with coexisting neuropsychiatric or cerebrovascular disorders or those who have a history of head trauma or brain surgery

Design outcomes

Primary

MeasureTime frameDescription
Post-transplant Neurological Complication28 days after transplantationincidence of Neurological Complication as a composite outcome (tremors, seizures, demyelination, posterior reversible encephalopathy syndrome, stroke)

Secondary

MeasureTime frameDescription
flow patterns throughout the transplant surgery and in the ICUintraoperative and 7 days after transplantionnormal, hyperemic, low-flow, or vasospastic flow by TCD

Countries

Egypt

Contacts

Primary ContactMoataz M Emara, MD, EDAIC
mm.emara@mans.edu.eg+201064048848
Backup ContactKareem M Abozeid, MSc
kareemmohabozeid27@gmail.com1557442411

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026